Health

Rapport Therapeutics, a company whose neuroscience technology comes from Johnson & Johnson, joined the public markets Friday, raising $154 million...

Consumers expect versatility, flexibility, speed, and convenience from their payment experiences, and those expectations increasingly are being applied to healthcare....

By BEN WHEATLEY The U.S. is in the midst of an ongoing—and still expanding—health care cost crisis. Even among people...

Why is it so hard to estimate the value of orphan drugs indicated for the...

Retailers have been plotting moves in healthcare over decades past — think of Minute Clinic that Target bought, which CVS...

By KIM BELLARD Imagine my excitement when I saw the headline: “Robot doctors at world’s first AI hospital can treat...

Delays in drug approvals cost pharmaceutical firms money. These costs include both lost sales as well as additional cost if...

This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended...

The World Health Organization recently went live with Sarah, its generative AI chatbot tasked with advising the public on leading...

By MATTHEW HOLT Today we’re going to have fun with show and tell. I’m going to show you how a...